1. Home
  2. ATNM vs BTCM Comparison

ATNM vs BTCM Comparison

Compare ATNM & BTCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATNM
  • BTCM
  • Stock Information
  • Founded
  • ATNM 2000
  • BTCM 2001
  • Country
  • ATNM United States
  • BTCM United States
  • Employees
  • ATNM N/A
  • BTCM N/A
  • Industry
  • ATNM Biotechnology: Pharmaceutical Preparations
  • BTCM EDP Services
  • Sector
  • ATNM Health Care
  • BTCM Technology
  • Exchange
  • ATNM Nasdaq
  • BTCM Nasdaq
  • Market Cap
  • ATNM 49.0M
  • BTCM 47.8M
  • IPO Year
  • ATNM N/A
  • BTCM 2013
  • Fundamental
  • Price
  • ATNM $1.72
  • BTCM $3.14
  • Analyst Decision
  • ATNM Strong Buy
  • BTCM Hold
  • Analyst Count
  • ATNM 2
  • BTCM 1
  • Target Price
  • ATNM $4.50
  • BTCM N/A
  • AVG Volume (30 Days)
  • ATNM 176.2K
  • BTCM 513.2K
  • Earning Date
  • ATNM 08-08-2025
  • BTCM 08-14-2025
  • Dividend Yield
  • ATNM N/A
  • BTCM N/A
  • EPS Growth
  • ATNM N/A
  • BTCM N/A
  • EPS
  • ATNM N/A
  • BTCM N/A
  • Revenue
  • ATNM N/A
  • BTCM $24,576,000.00
  • Revenue This Year
  • ATNM N/A
  • BTCM $14.32
  • Revenue Next Year
  • ATNM N/A
  • BTCM N/A
  • P/E Ratio
  • ATNM N/A
  • BTCM N/A
  • Revenue Growth
  • ATNM N/A
  • BTCM N/A
  • 52 Week Low
  • ATNM $1.03
  • BTCM $1.22
  • 52 Week High
  • ATNM $2.41
  • BTCM $8.07
  • Technical
  • Relative Strength Index (RSI)
  • ATNM 54.44
  • BTCM 51.15
  • Support Level
  • ATNM $1.60
  • BTCM $2.76
  • Resistance Level
  • ATNM $1.79
  • BTCM $3.24
  • Average True Range (ATR)
  • ATNM 0.10
  • BTCM 0.28
  • MACD
  • ATNM 0.01
  • BTCM 0.01
  • Stochastic Oscillator
  • ATNM 76.25
  • BTCM 38.21

About ATNM Actinium Pharmaceuticals Inc. (Delaware)

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.

About BTCM BIT Mining Limited ADS

BIT Mining Ltd is a cryptocurrency mining company, with a long-term plan to encompass the whole cryptocurrency value chain. Its business covers cryptocurrency mining, mining pool, data center operation and mining machine manufacturing. The company has a related and growing deployed Bitcoin mining machine capacity, owns three hydroelectric cryptocurrency mines with combined power capacity of 435MW and the entire mining pool business operated under BTC.com, including the domain name and wallet. It has also entered into a definitive agreement to acquire a 7 nanometer cryptocurrency mining machine manufacturer "Bee Computing", completing its vertical integration, making self-sufficient while also strengthening competitive position.

Share on Social Networks: